Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
Shaheen P Karim, Ron A Adelman Department of Ophthalmology and Visual Science, Yale University, New Haven, CT, USA Abstract: Central serous chorioretinopathy (CSCR) is an idiopathic disorder characterized by serous retinal detachments associated with focal leakage on fluorescein angiography and pigm...
Guardado en:
Autores principales: | Karim SP, Adelman RA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef90d94ff62d4c9a8c096f752a3dbc31 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
por: Sanguansak T, et al.
Publicado: (2015) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin Z, et al.
Publicado: (2014) -
Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010) -
Central serous chorioretinopathy: a pathogenetic model
por: et al, et al.
Publicado: (2011) -
Transpupillary thermotherapy for atypical central serous chorioretinopathy
por: Kawamura R, et al.
Publicado: (2012)